About: http://data.cimple.eu/news-article/28eaf33d2c2c757ea0c1e6abda1be27f7483c5437f51dd50599b78cf     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

AttributesValues
rdf:type
schema:articleBody
  • Centessa Pharmaceuticals ("Centessa") today announced that Moncef Slaoui, M.D., has stepped down from his position as chief scientific officer, advisor, effective immediately. Dr. Slaoui's departure from Centessa follows the reports of allegations of sexual harassment and inappropriate conduct towards an employee of GlaxoSmithKline plc ("GSK") several years ago which we learned of following the announcement by GSK. Saurabh Saha, M.D., Ph.D., chief executive officer of Centessa stated, "The Centessa management team and board of directors were troubled to learn of yesterday's news regarding Dr. Slaoui. Centessa is absolutely committed to fostering a culture of respect that is free from harassment and discrimination of any kind and are steadfastly committed to maintaining a work environment that is reflective of our strong values as a company." About Centessa Pharmaceuticals Centessa Pharmaceuticals Limited is a next-generation biopharmaceutical company that aims to reshape the traditional drug development process. The company applies an asset-centric R&D model at scale to advance a portfolio of highly validated programs led by industry leading teams. Each program is developed by a Centessa subsidiary and supported by a centralized infrastructure and the Centessa management team. The company is headquartered in Cambridge, Mass. For more information, visit www.centessa.com. View source version on businesswire.com: Contact Media: Dan Budwick, 1AB dan@1abmedia.com UK/European media enquiries Optimum Strategic Communications Mary Clark, Shabnam Bashir centessa@optimumcomms.com Swiss media enquiries VEITHing Spirit Marcus Veith marcus@vspirit.ch Cellphone: +41 79 20 75 111 © 2021 Business Wire, Inc. Disclaimer: This material is not an AFP editorial material, and AFP shall not bear responsibility for the accuracy of its content. In case you have any questions about the content, kindly refer to the contact person/entity mentioned in the text of the release.
schema:headline
  • Press Release from Business Wire: Centessa Pharmaceuticals
schema:mentions
schema:author
schema:datePublished
http://data.cimple...sPoliticalLeaning
http://data.cimple...logy#hasSentiment
http://data.cimple...readability_score
http://data.cimple...tology#hasEmotion
Faceted Search & Find service v1.16.115 as of Oct 09 2023


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 5 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software